Cover Image

Syntiron LLC的產品平台分析

Syntiron LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321343
出版日期 內容資訊 英文 23 Pages
Back to Top
Syntiron LLC的產品平台分析 Syntiron LLC - Product Pipeline Review - 2015
出版日期: 2015年07月31日 內容資訊: 英文 23 Pages

Syntiron LLC是總公司位於美國的生物科技企業,利用鐵調節細菌蛋白質來開發疫苗。擁有黃色葡萄球菌,大腸菌,炭疽菌,類鼻疽菌鼠疫菌等疫苗的開發中產品。

本報告提供Syntiron LLC 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,並彙整最新的企業新聞和發表,後期階段及中止的計劃相關資訊等。


Syntiron LLC 基本資料

  • Syntiron LLC 概要
  • 主要資訊
  • 企業資料

Syntiron LLC :R&D概要

  • 主要的治療範圍

Syntiron LLC :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Syntiron LLC :開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Syntiron LLC :藥物簡介

  • anthrax vaccine
  • Burkholderia pseudomallei vaccine
  • Escherichia coli vaccine
  • klebsiella pneumoniae vaccine
  • Pseudomonas aeruginosa vaccine
  • Staphylococcus aureus vaccine
  • Yersinia pestis vaccine

Syntiron LLC :開發平台分析

  • 各分子類型

Syntiron LLC :開發休止的計劃

Syntiron LLC :總公司和子公司的所在地

  • 總公司




Product Code: GMDHC07210CDB


Global Markets Direct's, 'Syntiron LLC - Product Pipeline Review - 2015', provides an overview of the Syntiron LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Syntiron LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides brief overview of Syntiron LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Syntiron LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Syntiron LLC's pipeline products

Reasons to buy

  • Evaluate Syntiron LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Syntiron LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Syntiron LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Syntiron LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Syntiron LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Syntiron LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Syntiron LLC Snapshot
    • Syntiron LLC Overview
    • Key Information
    • Key Facts
  • Syntiron LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Syntiron LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Syntiron LLC - Pipeline Products Glance
    • Syntiron LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Syntiron LLC - Drug Profiles
    • anthrax vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Burkholderia pseudomallei vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Escherichia coli vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Klebsiella pneumoniae vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Pseudomonas aeruginosa vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Staphylococcus aureus vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Yersinia pestis vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Syntiron LLC - Pipeline Analysis
  • Syntiron LLC - Pipeline Products by Molecule Type
  • Syntiron LLC - Dormant Projects
  • Syntiron LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Syntiron LLC, Key Information
  • Syntiron LLC, Key Facts
  • Syntiron LLC - Pipeline by Indication, 2015
  • Syntiron LLC - Pipeline by Stage of Development, 2015
  • Syntiron LLC - Monotherapy Products in Pipeline, 2015
  • Syntiron LLC - Preclinical, 2015
  • Syntiron LLC - Pipeline by Molecule Type, 2015
  • Syntiron LLC - Dormant Developmental Projects,2015

List of Figures

  • Syntiron LLC - Pipeline by Top 10 Indication, 2015
  • Syntiron LLC - Pipeline by Top 10 Molecule Type, 2015
Back to Top